Table 2.

Clinical Trials Evaluating the Efficacy of IL-6/IL-6R Blockade Therapy

Clinical Trial	Intervention
NCT04331795 (COVIDOSE) NCT04320615 (COVACTA) NCT04332913 (TOSCA) NCT04317092 (TOCOVID-19) NCT04335071 (CORON-ACT) NCT04315480 ChiCTR2000029765	tocilizumab
NCT04315298	sarilumab
NCT04310228	tocilizumab favipiravir
NCT04306705 (TACOS)	tocilizumab continuous renal replacement therapy standard of care
NCT04332094 (TOCOVID)	tocilizumab azithromycin hydroxychloroquine
NCT04341870 (CORIMUNO-VIRO)	sarilumab azithromycin hydroxychloroquine
NCT0433z638 (COV-AID)	tocilizumab siltuximab anakinra standard of care